Stocks and Investing Stocks and Investing
Wed, November 2, 2022

Patrick Trucchio Maintained (ALNY) at Strong Buy with Decreased Target to $415 on, Nov 2nd, 2022


Published on 2024-10-27 23:51:09 - WOPRAI, Patrick Trucchio
  Print publication without navigation


Patrick Trucchio of HC Wainwright & Co., Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy with Decreased Target from $430 to $415 on, Nov 2nd, 2022.

Patrick has made no other calls on ALNY in the last 4 months.



There are 12 other peers that have a rating on ALNY. Out of the 12 peers that are also analyzing ALNY, 5 agree with Patrick's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $210 on, Friday, October 28th, 2022
  • Jessica Fye of "JP Morgan" Maintained at Hold with Decreased Target to $200 on, Monday, October 24th, 2022
  • Gary Nachman of "BMO Capital" Maintained at Hold with Increased Target to $200 on, Friday, September 9th, 2022
  • David Lebowitz of "Morgan Stanley" Maintained at Hold with Decreased Target to $164 on, Friday, July 15th, 2022
  • Olivia Brayer of "Cantor Fitzgerald" Initiated at Hold and Held Target at $175 on, Wednesday, July 13th, 2022


These are the ratings of the 7 analyists that currently disagree with Patrick


  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $236 on, Friday, October 28th, 2022
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $270 on, Friday, October 28th, 2022
  • Maury Raycroft of "Jefferies" Maintained at Strong Buy with Increased Target to $232 on, Monday, October 3rd, 2022
  • Luca Issi of "RBC Capital" Maintained at Buy with Increased Target to $250 on, Tuesday, September 20th, 2022
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Increased Target to $256 on, Friday, September 9th, 2022
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $240 on, Thursday, August 4th, 2022
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $250 on, Thursday, August 4th, 2022
Contributing Sources